GATA-3 expression in male and female breast cancers: Comparison of clinicopathologic parameters and prognostic relevance

Human Pathology

Volumn 44, Issue 6, 2013, Pages 1065-1070

  Gonzalez, Raul S ^a   Wang, Jason ^a   Kraus, Teresa ^b   Sullivan, Harold ^a   Adams, Amy L ^a   Cohen, Cynthia ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

GATA 3; Immunopathology; Male breast cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR GATA 3;

ADULT; AGE; AGED; ARTICLE; BREAST CARCINOMA; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PROTEIN EXPRESSION; SEX DIFFERENCE; TUMOR VOLUME;

BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA, DUCTAL, BREAST; FEMALE; GATA3 TRANSCRIPTION FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, ESTROGEN; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84878108375     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2012.09.010     Document Type: Article

References (14)

1. R. Siegel, E. Ward, O. Brawley, and A. Jemal Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths CA Cancer J Clin 61 2011 212 236
2. V.R. Grann, A.B. Troxel, N.J. Zojwalla, J.S. Jacobson, D. Hershman, and A.I. Neugut Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma Cancer 103 2005 2241 2251
3. M. Lacroix, and G. Leclercq About GATA3, HNF3A, and XBP1, three genes co-expressed with the oestrogen receptor-alpha gene (ESR1) in breast cancer Mol Cell Endocrinol 219 2004 1 7
4. H. Van Esch, P. Groenen, and M.A. Nesbit GATA3 haplo-insufficiency causes human HDR syndrome Nature 406 2000 419 422
5. M.L. Asselin-Labat, K.D. Sutherland, and H. Barker Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation Nat Cell Biol 9 2007 201 209
6. S.H. Fang, Y. Chen, and R.J. Weigel GATA-3 as a marker of hormone response in breast cancer J Surg Res 157 2009 290 295
7. R.V. Hoch, D.A. Thompson, R.J. Baker, and R.J. Weigel GATA-3 is expressed in association with estrogen receptor in breast cancer Int J Cancer 84 1999 122 128
8. D. Voduc, M. Cheang, and T. Nielsen GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value Cancer Epidemiol Biomarkers Prev 17 2008 365 373
9. A. Albergaria, J. Paredes, and B. Sousa Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours Breast Cancer Res 11 2009 R40
10. J. Usary, V. Llaca, and G. Karaca Mutation of GATA3 in human breast tumors Oncogene 23 2004 7669 7678
11. R. Mehra, S. Varambally, and L. Ding Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis Cancer Res 65 2005 11259 11264
12. A.C. Wolff, M.E. Hammond, and J.N. Schwartz American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer Arch Pathol Lab Med 131 2007 18 43
13. J.D. Brenton, L.A. Carey, A.A. Ahmed, and C. Caldas Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 2005 7350 7360
14. P. Parikh, J.P. Palazzo, L.J. Rose, C. Daskalakis, and R.J. Weigel GATA-3 expression as a predictor of hormone response in breast cancer J Am Coll Surg 200 2005 705 710